New Drug Application (NDA) Submissions 505(b)(1) Or 505(b)(2)
There are clearly defined pathways for drug approval, and choosing the right regulatory pathway for your drug development program requires a thorough...
Stay updated with breaking news from Electronic Common Technical Document. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
There are clearly defined pathways for drug approval, and choosing the right regulatory pathway for your drug development program requires a thorough...
In clinical trials, pharmaceutical companies are seeking to optimize operations and improve efficiency by automating and enhancing processes through Artificial Intelligence (AI) and Machine Learning (ML). One area where this can reap tangible benefits across clinical trials is in data processing. A typical clinical trial generates over 13,000 documents in various formats (text, voice, video, apps, and web entries), making data gathering, organization and analysis challenging. It’s here that implementing automated Intelligent Document Processing (IDP) can significantly benefit clinical t...
/PRNewswire/ -- Professionals in the life sciences industry rely on unique regulatory affairs expertise to effectively manage the full end-to-end Electronic...
The Investigational New Drug Application or IND is a key step in this journey.
LONDON and NEW YORK, Aug. 16, 2022 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO; LSE: OKYO) (the "Company") is pleased to announce its final audited results for the year ended 31 March 2022. Summary of OKYO-101 studies during the last year OK-101